KOL Finder awarded with the seal of approval of the European Commission

โ€Munich, November 14, 2017 - The ysura KOL Finder project, which revolutionizes the identification of opinion leaders in the pharmaceutical industry, received the rare Seal of Excellence from the European Commission. In a very competitive evaluation, the application convinced in all strict Horizon 2020 evaluation criteria for the three award criteria (excellence, impact, quality and efficiency of implementation), thus making funding from the EU budget Horizon 2020 possible.

โ€

As part of this evaluation, the EU asked leading scientists, pharmaceutical industry executives and academics from across Europe to critically assess and review the applications. The KOL Finder identifies the most influential medical experts (KeyOpinion Leaders) by the number and importance of their publications, speeches, board memberships and social media activities. While KOLs have so far only been identified by interviewing HCPs to evaluate other HCPs, ysura creates a fact-based overview of HCPs that actually have influence in certain therapeutic areas. More importantly, the KOLFinder can recognize the typical activity patterns of future KOLs early in their careers.

โ€

โ€

โ€

โ€

โ€

โ€

โ€

โ€

โ€

โ€

โ€

โ€

โ€

โ€

โ€

โ€

โ€žWe are pleased that the EU has recognized the potential of the KOLFinder," said Keith Gruen, co-founder of ysura. "The seal is further proof of the importance of KOL marketing needs for European pharmaceutical companies.โ€œ

โ€

โ€

โ€

โ€

โ€

โ€

โ€